Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Thumbnail

How the science behind COVID-19 vaccines could transform care for heart attack patients

A technique seen in the Pfizer-BioNTech and Moderna COVID-19 vaccines may be able to help heart cells repair themselves, according to new research out of the Netherlands. 

Thumbnail

Unpaid student loan debt is bad for the heart

An American Journal of Preventive Medicine study highlights higher rates of cardiovascular disease for adults who fail to pay down student debt.

Thumbnail

USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older

These recommendations, the group emphasized, do not include patients with a history of CVD or those who are already taking aspirin for another reason.

election 2020

Biden-Trump presidential election linked to a higher heart attack risk among white, male and older individuals

“There is a need for awareness of this higher risk of CVD, and further research is warranted to identify strategies that mitigate cardiovascular risk during notable political events,” researchers explained. 

Thumbnail

Mental illness strongly linked with higher CVD mortality

The associations between schizophrenia or bipolar disorder and cardiovascular mortality have grown in recent decades.

Deaths from MI, stroke and pulmonary embolism are down among kidney patients receiving dialysis

The new analysis, published in JAMA Network Open, focused on more than 220,000 dialysis patients treated from 1998 to 2015. 

PCI

Is PCI without stenting safe for low-risk STEMI patients?

The study's authors examined data from the DANAMI-3 trial, focusing on such outcomes as all-cause mortality, recurrent MI and target vessel revascularization.

Thumbnail

PCI vs. CABG for left main disease: Key takeaways from a new meta-analysis

Researchers explored data from five different randomized controlled trials, publishing their analysis in the American Journal of Cardiology.